|
US2669583A
(en)
*
|
|
1954-02-16 |
|
X-amroo-zralkoxbbenzamdjes |
|
US2006735A
(en)
*
|
1932-11-17 |
1935-07-02 |
Gen Aniline Works Inc |
Nitro-aryl amino-aryl amines
|
|
NL247377A
(enExample)
*
|
1957-11-25 |
|
|
|
|
US3161564A
(en)
|
1960-10-03 |
1964-12-15 |
Salsbury S Lab Dr |
Veterinary composition containing halo-nitro-benzamides and methods of using same
|
|
US3228833A
(en)
*
|
1962-12-17 |
1966-01-11 |
Sterling Drug Inc |
Anticoccidial compositions and methods of using same
|
|
GB1493685A
(en)
*
|
1970-12-15 |
1977-11-30 |
May & Baker Ltd |
8-azapurinones
|
|
AR204004A1
(es)
|
1973-04-02 |
1975-11-12 |
Lilly Co Eli |
Procedimientos para preparar derivados de vinblastina leurosidina y leurocristina
|
|
FR2456731A1
(fr)
|
1979-05-16 |
1980-12-12 |
Choay Sa |
Nouveaux derives substitues d'ary
|
|
JPS6019790A
(ja)
|
1983-07-14 |
1985-01-31 |
Yakult Honsha Co Ltd |
新規なカンプトテシン誘導体
|
|
US5032617A
(en)
*
|
1985-05-03 |
1991-07-16 |
Sri International |
Substituted benzamide radiosensitizers
|
|
US5041653A
(en)
|
1985-05-03 |
1991-08-20 |
Sri International |
Substituted benzamide radiosensitizers
|
|
US5215738A
(en)
*
|
1985-05-03 |
1993-06-01 |
Sri International |
Benzamide and nicotinamide radiosensitizers
|
|
US6407079B1
(en)
*
|
1985-07-03 |
2002-06-18 |
Janssen Pharmaceutica N.V. |
Pharmaceutical compositions containing drugs which are instable or sparingly soluble in water and methods for their preparation
|
|
ATE107705T1
(de)
*
|
1986-01-17 |
1994-07-15 |
Ronald W Pero |
Test zur feststellung der empfänglichkeit für dns-assoziierte krankheiten.
|
|
US5283352A
(en)
*
|
1986-11-28 |
1994-02-01 |
Orion-Yhtyma Oy |
Pharmacologically active compounds, methods for the preparation thereof and compositions containing the same
|
|
US5223608A
(en)
*
|
1987-08-28 |
1993-06-29 |
Eli Lilly And Company |
Process for and intermediates of 2',2'-difluoronucleosides
|
|
US4923885A
(en)
*
|
1988-08-19 |
1990-05-08 |
Merck & Co., Inc. |
5-amino-1-(4-naphthoylbenzyl)-1,2,3-triazole-4-carboxamides and analogs as antiproliferative agents
|
|
US5177075A
(en)
*
|
1988-08-19 |
1993-01-05 |
Warner-Lambert Company |
Substituted dihydroisoquinolinones and related compounds as potentiators of the lethal effects of radiation and certain chemotherapeutic agents; selected compounds, analogs and process
|
|
AU6518890A
(en)
|
1989-09-26 |
1991-04-28 |
Regents Of The University Of California, The |
6-amino-1,2-benzopyrones useful for treatment of viral diseases
|
|
US5719151A
(en)
*
|
1990-05-04 |
1998-02-17 |
Shall; Sydney |
Substituted benzene compounds
|
|
US5633282A
(en)
*
|
1990-05-25 |
1997-05-27 |
British Technology Group Limited |
Inhibition of viral infection
|
|
US5631038A
(en)
*
|
1990-06-01 |
1997-05-20 |
Bioresearch, Inc. |
Specific eatable taste modifiers
|
|
US5637618A
(en)
*
|
1990-06-01 |
1997-06-10 |
Bioresearch, Inc. |
Specific eatable taste modifiers
|
|
US5232735A
(en)
|
1990-06-01 |
1993-08-03 |
Bioresearch, Inc. |
Ingestibles containing substantially tasteless sweetness inhibitors as bitter taste reducers or substantially tasteless bitter inhibitors as sweet taste reducers
|
|
JP2848958B2
(ja)
*
|
1990-09-28 |
1999-01-20 |
スミスクライン・ビーチャム・コーポレイション |
水溶性カンプトテシン類似体、方法および手段
|
|
US5484951A
(en)
*
|
1990-10-19 |
1996-01-16 |
Octamer, Incorporated |
5-iodo-6-amino-6-nitroso-1,2-benzopyrones useful as cytostatic and antiviral agents
|
|
US5243050A
(en)
|
1990-12-20 |
1993-09-07 |
North Carolina State University |
Alkylpyridone DE ring intermediates useful for the manufacture of camptothecin and camptothecin analogs
|
|
US5162532A
(en)
|
1990-12-20 |
1992-11-10 |
North Carolina State University |
Intermediates and method of making camptothecin and camptothecin analogs
|
|
US5247089A
(en)
|
1990-12-20 |
1993-09-21 |
North Carolina State University |
Method of making intermediates useful for the manufacture of camptothecin and camptothecin analogs
|
|
US5200524A
(en)
*
|
1990-12-20 |
1993-04-06 |
North Carolina State University |
Camptothecin intermediates and method of making same
|
|
US5191082A
(en)
*
|
1990-12-20 |
1993-03-02 |
North Carolina State University |
Camptothecin intermediate and method of making camptothecin intermediates
|
|
AU1746392A
(en)
|
1991-04-10 |
1992-11-17 |
Octamer, Inc. |
A method for inhibition of retroviral replication
|
|
US5877185A
(en)
|
1991-10-22 |
1999-03-02 |
Octamer, Inc. |
Synergistic compositions useful as anti-tumor agents
|
|
US5464871A
(en)
|
1993-05-12 |
1995-11-07 |
Octamer, Inc. |
Aromatic nitro and nitroso compounds and their metabolites useful as anti-viral and anti-tumor agents
|
|
US5516941A
(en)
*
|
1991-10-22 |
1996-05-14 |
Octamer, Inc. |
Specific inactivators of "retroviral" (asymmetric) zinc fingers
|
|
US5482975A
(en)
*
|
1991-10-22 |
1996-01-09 |
Octamer, Inc. |
Adenosine diphosphoribose polymerase binding nitroso aromatic compounds useful as retroviral inactivating agents, anti-retroviral agents and anti-tumor agents
|
|
US5473074A
(en)
|
1991-10-22 |
1995-12-05 |
Octamer, Incorporated |
Adenosine diphosphoribose polymerase binding nitroso aromatic compounds useful as retroviral inactivating agents, anti-retroviral agents and anti-tumor agents-54
|
|
US5753674A
(en)
*
|
1991-10-22 |
1998-05-19 |
Octamer, Inc. |
Adenosine diphosphoribose polymerase binding nitroso aromatic compounds useful as retroviral inactivating agents, anti-retroviral agents, anti-retroviral agents and anti-tumor agents
|
|
FR2689009B1
(fr)
*
|
1992-03-25 |
1995-06-23 |
Oreal |
Utilisation en teinture, de metaphenylene-diamines soufrees, composition tinctoriale et procede de teinture, nouvelles metaphenylenediamines soufrees.
|
|
KR950703280A
(ko)
*
|
1992-09-09 |
1995-09-20 |
미리암 디.메코너헤이 |
제초성 벤젠 화합물(Herbicidal Benzene Compounds)
|
|
US5262564A
(en)
|
1992-10-30 |
1993-11-16 |
Octamer, Inc. |
Sulfinic acid adducts of organo nitroso compounds useful as retroviral inactivating agents anti-retroviral agents and anti-tumor agents
|
|
US5783599A
(en)
|
1993-02-24 |
1998-07-21 |
Octamer Inc |
Methods of treating cancer and viral infections with 5-iodo-6-amino-and 5-iodo-6-nitroso-1 2-benzopyrones
|
|
JP3025602B2
(ja)
*
|
1993-05-21 |
2000-03-27 |
デビオファーム エス．アー． |
光学的に高純度なシス−オキザラート（トランス−ｌ−１，２−シクロヘキサンジアミン）白金（ＩＩ）錯体の製造方法
|
|
DZ1781A1
(fr)
|
1993-05-21 |
2002-02-17 |
Radopah Ltd |
Agents d'arylation.
|
|
US6015792A
(en)
*
|
1993-05-26 |
2000-01-18 |
Bioresearch, Inc. |
Specific eatable taste modifiers
|
|
US6008250A
(en)
|
1993-05-26 |
1999-12-28 |
Bioresearch, Inc. |
Specific eatable taste modifiers
|
|
JPH06345723A
(ja)
*
|
1993-06-10 |
1994-12-20 |
Sumitomo Seika Chem Co Ltd |
メルカプトベンズアミドの製造法
|
|
JP3495072B2
(ja)
*
|
1993-12-29 |
2004-02-09 |
住友精化株式会社 |
１，２−ベンズイソチアゾール−３−オン類の製造方法
|
|
GB9404485D0
(en)
*
|
1994-03-09 |
1994-04-20 |
Cancer Res Campaign Tech |
Benzamide analogues
|
|
JP3720388B2
(ja)
*
|
1994-06-08 |
2005-11-24 |
住友精化株式会社 |
イソチアゾロン誘導体の製造方法
|
|
WO1996011906A1
(en)
*
|
1994-10-17 |
1996-04-25 |
Novartis Ag |
Process for the preparation of substituted 3-aminobenzonitriles
|
|
JP3777455B2
(ja)
*
|
1994-11-24 |
2006-05-24 |
住友精化株式会社 |
芳香族またはヘテロ芳香族硫黄化合物の製造方法
|
|
US5589483A
(en)
*
|
1994-12-21 |
1996-12-31 |
Geron Corporation |
Isoquinoline poly (ADP-ribose) polymerase inhibitors to treat skin diseases associated with cellular senescence
|
|
GB9508538D0
(en)
*
|
1995-04-27 |
1995-06-14 |
Zeneca Ltd |
Quinazoline derivatives
|
|
JP3154399B2
(ja)
|
1996-07-04 |
2001-04-09 |
デビオファーム エス．アー． |
白金化合物の製造方法
|
|
PT841924E
(pt)
|
1995-08-02 |
2003-02-28 |
Univ Newcastle Ventures Ltd |
Compostos de benzimidazolo
|
|
GB9615619D0
(en)
|
1996-03-18 |
1996-09-04 |
Radopath Ltd |
Costimulation of TcR/CD3-induced T-Lymphocytes
|
|
US5837729A
(en)
|
1996-04-26 |
1998-11-17 |
Metatron, Inc. |
Methods for treating and preventing HIV infection using acetaminophen and derivatives thereof
|
|
US6017958A
(en)
*
|
1996-06-04 |
2000-01-25 |
Octamer, Inc. |
Method of treating malignant tumors with thyroxine analogues having no significant hormonal activity
|
|
US5736576A
(en)
*
|
1996-06-04 |
1998-04-07 |
Octamer, Inc. |
Method of treating malignant tumors with thyroxine analogues having no significant hormonal activity
|
|
US5981575A
(en)
|
1996-11-15 |
1999-11-09 |
Johns Hopkins University, The |
Inhibition of fatty acid synthase as a means to reduce adipocyte mass
|
|
GB9702701D0
(en)
|
1997-02-01 |
1997-04-02 |
Univ Newcastle Ventures Ltd |
Quinazolinone compounds
|
|
US20050287120A1
(en)
|
1997-03-21 |
2005-12-29 |
Fisher Paul B |
Cancer - targeted viral vectors
|
|
IL132029A0
(en)
*
|
1997-03-26 |
2001-03-19 |
Biosource Tech Inc |
Pharmaceutical compositions containing di-aryl ethers
|
|
WO1998045253A1
(en)
|
1997-04-10 |
1998-10-15 |
Isotechnika, Inc. |
Activated iododerivatives for the treatment of cancer and aids
|
|
US5908861A
(en)
|
1997-05-13 |
1999-06-01 |
Octamer, Inc. |
Methods for treating inflammation and inflammatory disease using pADPRT inhibitors
|
|
US6514983B1
(en)
*
|
1997-09-03 |
2003-02-04 |
Guilford Pharmaceuticals Inc. |
Compounds, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
|
|
US6235748B1
(en)
*
|
1997-09-03 |
2001-05-22 |
Guilford Pharmaceuticals Inc. |
Oxo-substituted compounds, process of making, and compositions and methods for inhibiting parp activity
|
|
US6426415B1
(en)
|
1997-09-03 |
2002-07-30 |
Guilford Pharmaceuticals Inc. |
Alkoxy-substituted compounds, methods and compositions for inhibiting parp activity
|
|
US6121278A
(en)
|
1997-09-03 |
2000-09-19 |
Guilford Pharmaceuticals, Inc. |
Di-n-heterocyclic compounds, methods, and compositions for inhibiting parp activity
|
|
US5922775A
(en)
|
1997-10-23 |
1999-07-13 |
Octamer, Inc. |
Method of treating malignant tumors with ketone thyroxine analogues having no significant hormonal activity
|
|
US6380193B1
(en)
*
|
1998-05-15 |
2002-04-30 |
Guilford Pharmaceuticals Inc. |
Fused tricyclic compounds, methods and compositions for inhibiting PARP activity
|
|
WO1999059973A1
(en)
|
1998-05-15 |
1999-11-25 |
Guilford Pharmaceuticals Inc. |
Carboxamide compounds, compositions, and methods for inhibiting parp activity
|
|
US6395749B1
(en)
*
|
1998-05-15 |
2002-05-28 |
Guilford Pharmaceuticals Inc. |
Carboxamide compounds, methods, and compositions for inhibiting PARP activity
|
|
CO5070700A1
(es)
|
1998-06-05 |
2001-08-28 |
Basf Ag |
Genes novedosos de (adp-ribosa) polimerasa
|
|
EP1391457B1
(de)
|
1998-11-03 |
2013-12-25 |
AbbVie Deutschland GmbH & Co KG |
Substituierte 2-Phenylbenzimidazole und deren Verwendung als PARP Inhibitoren
|
|
USRE39608E1
(en)
|
1998-11-27 |
2007-05-01 |
Abbott Gmbh & Co. Kg |
Substituted benzimidazoles and their use as PARP inhibitors
|
|
JP3552934B2
(ja)
|
1998-12-24 |
2004-08-11 |
セントラル硝子株式会社 |
安息香酸アミド類の製造方法
|
|
US6326517B1
(en)
|
1998-12-10 |
2001-12-04 |
Central Glass Company, Limited |
Method of producing benzamides
|
|
US6387902B1
(en)
*
|
1998-12-31 |
2002-05-14 |
Guilford Pharmaceuticals, Inc. |
Phenazine compounds, methods and pharmaceutical compositions for inhibiting PARP
|
|
US6201020B1
(en)
*
|
1998-12-31 |
2001-03-13 |
Guilford Pharmaceuticals, Inc. |
Ortho-diphenol compounds, methods and pharmaceutical compositions for inhibiting parp
|
|
EE05006B1
(et)
|
1999-01-11 |
2008-04-15 |
Agouron Pharmaceuticals, Inc. |
Polü(ADP-riboos)polümeraaside tritsüklilised inhibiitorid ja neid sisaldavad farmatseutilised kompositsioonid
|
|
KR20010101675A
(ko)
*
|
1999-01-26 |
2001-11-14 |
우에노 도시오 |
2ｈ-프탈라진-1-온 유도체 및 그 유도체를 유효 성분으로하는 약제
|
|
US6423696B1
(en)
|
1999-04-16 |
2002-07-23 |
The United States Of America, As Represented By The Department Of Health & Human Services |
Inhibition of arylamine N-acetyl transferase
|
|
DE19921567A1
(de)
*
|
1999-05-11 |
2000-11-16 |
Basf Ag |
Verwendung von Phthalazine-Derivaten
|
|
US6653316B1
(en)
*
|
1999-05-19 |
2003-11-25 |
Pharmacia Corporation |
Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade
|
|
TWI262914B
(en)
*
|
1999-07-02 |
2006-10-01 |
Agouron Pharma |
Compounds and pharmaceutical compositions for inhibiting protein kinases
|
|
GB9915995D0
(en)
|
1999-07-09 |
1999-09-08 |
Ahmed S |
Non-steroidal sulphamate compounds for use as oestrone sulphatase inhibitors
|
|
ECSP003637A
(es)
*
|
1999-08-31 |
2002-03-25 |
Agouron Pharma |
Inhibidores triciclicos de poli (adp-ribosa) polimerasas
|
|
US6803457B1
(en)
|
1999-09-30 |
2004-10-12 |
Pfizer, Inc. |
Compounds for the treatment of ischemia
|
|
US6562830B1
(en)
*
|
1999-11-09 |
2003-05-13 |
Cell Pathways, Inc. |
Method of treating a patient having precancerous lesions with phenyl quinazolinone derivatives
|
|
US6476048B1
(en)
|
1999-12-07 |
2002-11-05 |
Inotek Pharamaceuticals Corporation |
Substituted phenanthridinones and methods of use thereof
|
|
US6277990B1
(en)
|
1999-12-07 |
2001-08-21 |
Inotek Corporation |
Substituted phenanthridinones and methods of use thereof
|
|
US7122679B2
(en)
*
|
2000-05-09 |
2006-10-17 |
Cephalon, Inc. |
Multicyclic compounds and the use thereof
|
|
WO2001090077A1
(en)
*
|
2000-05-19 |
2001-11-29 |
Guilford Pharmaceuticals, Inc. |
Sulfonamide and carbamide derivatives of 6(5h)phenanthridinones and their uses
|
|
ATE430745T1
(de)
*
|
2000-10-12 |
2009-05-15 |
Merck & Co Inc |
Aza- und polyaza naphthalenyl karboxamide als inhibitoren der hiv-integrase
|
|
ITMI20002358A1
(it)
*
|
2000-10-31 |
2002-05-01 |
Flavio Moroni |
Derivati di tieno ,2, 3-c|isochinolin-3-one come inibitori della poli(a dp-ribosio)polimerasi
|
|
AUPR201600A0
(en)
*
|
2000-12-11 |
2001-01-11 |
Fujisawa Pharmaceutical Co., Ltd. |
Quinazolinone derivative
|
|
DE10064423A1
(de)
|
2000-12-21 |
2002-07-04 |
Symyx Technologies Inc |
Verfahren zur Herstellung substituierter organischer Verbindungen und Verwendung von Katalysatoren für Substitutionsreaktionen
|
|
WO2002055076A1
(en)
|
2001-01-04 |
2002-07-18 |
Daiichi Pharmaceutical Co., Ltd. |
Cyclodextrin-containing pharmaceutical preparation
|
|
US20020142334A1
(en)
|
2001-01-30 |
2002-10-03 |
Brown Janice A. |
Methods of detecting poly(ADP-ribose) polymerase enzymatic activity
|
|
US20020164633A1
(en)
|
2001-04-20 |
2002-11-07 |
Inotek Pharmaceuticals Corporation |
Cell-based assay for detecting activation of poly (ADP-ribose) polymerase
|
|
DE60218458T2
(de)
|
2001-05-08 |
2007-11-15 |
Kudos Pharmaceuticals Ltd. |
Isochinolinon derivate als parp inhibitoren
|
|
AU2002317377A1
(en)
|
2001-07-20 |
2003-03-03 |
Cancer Research Technology Limited |
Biphenyl apurinic/apyrimidinic site endonuclease inhibitors to treat cancer
|
|
CA2456985A1
(en)
|
2001-08-15 |
2003-02-27 |
Icos Corporation |
2h-phthalazin-1-ones and methods for use thereof
|
|
US20050113283A1
(en)
*
|
2002-01-18 |
2005-05-26 |
David Solow-Cordero |
Methods of treating conditions associated with an EDG-4 receptor
|
|
AUPS019702A0
(en)
*
|
2002-01-29 |
2002-02-21 |
Fujisawa Pharmaceutical Co., Ltd. |
Condensed heterocyclic compounds
|
|
AUPS137402A0
(en)
|
2002-03-26 |
2002-05-09 |
Fujisawa Pharmaceutical Co., Ltd. |
Novel tricyclic compounds
|
|
KR20040097237A
(ko)
|
2002-03-26 |
2004-11-17 |
반유 세이야꾸 가부시끼가이샤 |
항종양성 인돌로피롤로카바졸 유도체와 기타 항암제의 병용
|
|
AU2003220935A1
(en)
*
|
2002-04-03 |
2003-10-13 |
Sumitomo Pharmaceuticals Company, Limited. |
Benzamide derivatives
|
|
US20040034078A1
(en)
*
|
2002-06-14 |
2004-02-19 |
Agouron Pharmaceuticals, Inc. |
Benzimidazole inhibitors of poly(ADP-ribosyl) polymerase
|
|
US7179484B2
(en)
*
|
2002-11-06 |
2007-02-20 |
Azaya Therapeutics, Inc. |
Protein-stabilized liposomal formulations of pharmaceutical agents
|
|
JP2006522088A
(ja)
|
2003-03-31 |
2006-09-28 |
ファイザー・インク |
ポリ（ａｄｐ−リボース）ポリメラーゼの三環系阻害剤の塩
|
|
CA2524305C
(en)
*
|
2003-05-01 |
2015-12-08 |
Imclone Systems Incorporated |
Fully human antibodies directed against the human insulin-like growth factor-1 receptor
|
|
WO2004105700A2
(en)
*
|
2003-05-28 |
2004-12-09 |
Guildford Pharmaceuticals, Inc. |
Compounds, methods and pharmaceutical compositions for inhibiting parp
|
|
US20050004038A1
(en)
*
|
2003-06-27 |
2005-01-06 |
Lyon Robert P. |
Bivalent inhibitors of Glutathione-S-Transferases
|
|
PL1660095T3
(pl)
|
2003-07-25 |
2010-07-30 |
Cancer Research Tech Ltd |
Tricykliczne inhibitory PARP
|
|
AU2004266572A1
(en)
*
|
2003-08-01 |
2005-03-03 |
Wyeth Holdings Corporation |
Use of combination of an epidermal growth factor receptor kinase inhibitor and cytotoxic agents for treatment and inhibition of cancer
|
|
JP2007504238A
(ja)
*
|
2003-09-04 |
2007-03-01 |
アベンティス・ファーマスーティカルズ・インコーポレイテツド |
ポリ（ａｄｐ−リボース）ポリメラーゼ（ｐａｒｐ）の阻害剤としての置換インドール
|
|
WO2005023765A1
(en)
*
|
2003-09-11 |
2005-03-17 |
Pharmacia & Upjohn Company Llc |
Method for catalyzing amidation reactions by the presence of co2
|
|
AU2004295058B9
(en)
|
2003-11-20 |
2011-06-30 |
Janssen Pharmaceutica N.V. |
6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors
|
|
EA011211B1
(ru)
|
2003-11-20 |
2009-02-27 |
Янссен Фармацевтика Н. В. |
7-фенилалкилзамещённые 2-хинолиноны и 2-хиноксалиноны в качестве ингибиторов поли(адф-рибоза)полимеразы
|
|
TWI338000B
(en)
|
2003-12-01 |
2011-03-01 |
Kudos Pharm Ltd |
Dna damage repair inhibitors for treatment of cancer
|
|
EP1709012B1
(en)
|
2003-12-05 |
2015-07-29 |
Janssen Pharmaceutica NV |
6-substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose)polymerase inhibitors
|
|
WO2005058843A1
(en)
|
2003-12-10 |
2005-06-30 |
Janssen Pharmaceutica N.V. |
Substituted 6-cyclohexylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors
|
|
US7439031B2
(en)
*
|
2003-12-15 |
2008-10-21 |
The Trustees Of The University Of Pennsylvania |
Method of identifying compounds that induce cell death by necrosis
|
|
US7680864B2
(en)
|
2004-03-02 |
2010-03-16 |
Intel Corporation |
Method and apparatus for managing access to stored objects based on retention policy
|
|
PE20060285A1
(es)
|
2004-03-30 |
2006-05-08 |
Aventis Pharma Inc |
Piridonas sustituidas como inhibidores de pol(adp-ribosa)-polimerasa (parp)
|
|
JP2005336083A
(ja)
|
2004-05-26 |
2005-12-08 |
Sumitomo Chemical Co Ltd |
芳香族アミノ化合物の製造方法
|
|
SG154432A1
(en)
|
2004-06-30 |
2009-08-28 |
Janssen Pharmaceutica Nv |
Quinazolinedione derivatives as parp inhibitors
|
|
JP4852540B2
(ja)
|
2004-06-30 |
2012-01-11 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
Ｐａｒｐ阻害剤としてのフタラジン誘導体
|
|
WO2006003150A1
(en)
|
2004-06-30 |
2006-01-12 |
Janssen Pharmaceutica N.V. |
Substituted 2-alkyl quinazolinone derivatives as parp inhibitors
|
|
US20060035890A1
(en)
|
2004-08-10 |
2006-02-16 |
Amit Banerjee |
Compounds and methods for the treatment of ubiquitin conjugating disorders
|
|
GB0419072D0
(en)
*
|
2004-08-26 |
2004-09-29 |
Kudos Pharm Ltd |
Phthalazinone derivatives
|
|
JP2008513435A
(ja)
|
2004-09-22 |
2008-05-01 |
ファイザー・インク |
ポリ（ａｄｐ−リボース）ポリメラーゼ阻害剤を含む治療用組成物
|
|
ATE551345T1
(de)
*
|
2004-09-22 |
2012-04-15 |
Pfizer |
Polymorphe formen des phosphatsalzes von 8-fluor- 2-ä4-ä(methylamino)methylüphenylü-1,3,4,5- tetrahydro-6h-azepinoä5,4,3-cdüindol-6-on
|
|
DE602005023333D1
(de)
*
|
2004-10-15 |
2010-10-14 |
Takeda Pharmaceutical |
Kinaseinhibitoren
|
|
DE102004050196A1
(de)
|
2004-10-15 |
2006-04-20 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte 2-Pyridon-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament
|
|
US20060094676A1
(en)
*
|
2004-10-29 |
2006-05-04 |
Ronit Lahav |
Compositions and methods for treating cancer using compositions comprising an inhibitor of endothelin receptor activity
|
|
AU2005297848B2
(en)
|
2004-10-29 |
2011-03-17 |
Msd K.K. |
Novel aminopyridine derivatives having selective Aurora-A inhibitory effect
|
|
CN1768733A
(zh)
|
2004-11-02 |
2006-05-10 |
上海富海科申药业有限公司 |
芳香硝基化合物在制备治疗艾滋病药物中的应用
|
|
CN1768732A
(zh)
|
2004-11-02 |
2006-05-10 |
上海富海科申药业有限公司 |
芳香硝基化合物在制备治疗肿瘤药物中的应用
|
|
DE102005023834A1
(de)
|
2004-11-20 |
2006-05-24 |
Bayer Healthcare Ag |
Substituierte[(Phenylethanoyl)amino]benzamide
|
|
GB0428111D0
(en)
|
2004-12-22 |
2005-01-26 |
Kudos Pharm Ltd |
Pthalazinone derivatives
|
|
WO2006078503A2
(en)
|
2005-01-07 |
2006-07-27 |
Arqule, Inc. |
Compositions for modulation of parp and methods for screening for same
|
|
WO2006110683A1
(en)
|
2005-04-11 |
2006-10-19 |
Abbott Laboratories |
2-substituted-1h-benzimidazole-4-carboxamides are parp inhibitors
|
|
TWI375673B
(en)
|
2005-04-11 |
2012-11-01 |
Abbott Lab |
1h-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position are potent parp inhibitors
|
|
BRPI0611814A2
(pt)
*
|
2005-06-10 |
2008-12-09 |
Bipar Sciences Inc |
moduladores parp e tratamento de cÂnceres
|
|
RU2447889C2
(ru)
|
2005-07-18 |
2012-04-20 |
Бипар Сайенсиз, Инк. |
Способ лечения рака (варианты)
|
|
EP2329818A1
(en)
|
2006-01-17 |
2011-06-08 |
Abbott Laboratories |
Combination therapy with PARP inhibitors
|
|
US20080293795A1
(en)
|
2006-01-17 |
2008-11-27 |
Abbott Laboratories |
Combination therapy with parp inhibitors
|
|
AU2007228984B2
(en)
|
2006-03-22 |
2012-05-03 |
Syncore Biotechnology Co., Ltd |
Treatment of triple receptor negative breast cancer
|
|
US20070292883A1
(en)
|
2006-06-12 |
2007-12-20 |
Ossovskaya Valeria S |
Method of treating diseases with PARP inhibitors
|
|
US20080262062A1
(en)
|
2006-11-20 |
2008-10-23 |
Bipar Sciences, Inc. |
Method of treating diseases with parp inhibitors
|
|
US20100160442A1
(en)
*
|
2006-07-18 |
2010-06-24 |
Ossovskaya Valeria S |
Formulations for cancer treatment
|
|
DE102006037399A1
(de)
*
|
2006-08-10 |
2008-02-14 |
Archimica Gmbh |
Verfahren zur Herstellung von Arylaminen
|
|
CA2662337A1
(en)
*
|
2006-09-05 |
2008-03-13 |
Bipar Sciences, Inc. |
Inhibition of fatty acid synthesis by parp inhibitors and methods of treatment thereof
|
|
AU2007292302A1
(en)
*
|
2006-09-05 |
2008-03-13 |
Bipar Sciences, Inc. |
Methods for designing PARP inhibitors and uses thereof
|
|
CN101522609A
(zh)
|
2006-09-05 |
2009-09-02 |
彼帕科学公司 |
癌症的治疗
|
|
US7538252B2
(en)
|
2006-09-05 |
2009-05-26 |
Bipar Sciences, Inc. |
Drug design for tubulin inhibitors, compositions, and methods of treatment thereof
|
|
CN101190211B
(zh)
|
2006-11-23 |
2011-08-10 |
上海富海科申药业有限公司 |
芳香硝基化合物在制备治疗病毒性肝炎药物中的应用
|
|
EA016079B1
(ru)
|
2007-01-10 |
2012-01-30 |
Институто Ди Ричерке Ди Биолоджиа Молеколаре П. Анджелетти Спа |
Амидзамещенные индазолы в качестве ингибиторов поли(adp-рибоза)полимеразы (parp)
|
|
UA100852C2
(ru)
|
2007-01-16 |
2013-02-11 |
Байпар Сайенсиз, Инк. |
Композиции для лечения рака
|
|
HRP20120346T1
(hr)
|
2007-03-08 |
2012-05-31 |
Janssen Pharmaceutica N.V. |
Derivati kinolinona kao parp i tank inhibitori
|
|
EP2211854A4
(en)
*
|
2007-10-19 |
2011-01-12 |
Bipar Sciences Inc |
METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER USING BENZOPYRONE-TYPE PARP INHIBITORS
|
|
JP2011503111A
(ja)
|
2007-11-12 |
2011-01-27 |
バイパー サイエンシズ，インコーポレイティド |
Ｐａｒｐ阻害剤単独又は抗腫瘍剤との組み合わせによる乳がんの治療
|
|
CA2705417A1
(en)
|
2007-11-12 |
2009-05-22 |
Bipar Sciences, Inc. |
Treatment of uterine cancer and ovarian cancer with a parp inhibitor alone or in combination with anti-tumor agents
|
|
KR20100102637A
(ko)
|
2007-12-07 |
2010-09-24 |
바이파 사이언스 인코포레이티드 |
토포이소머라제 억제제 및 ｐａｒｐ 억제제의 병용물에 의한 암의 치료
|
|
US20090275608A1
(en)
|
2008-02-04 |
2009-11-05 |
Bipar Sciences, Inc. |
Methods of diagnosing and treating parp-mediated diseases
|
|
KR20110113648A
(ko)
|
2009-02-04 |
2011-10-17 |
바이파 사이언스 인코포레이티드 |
Ｐａｒｐ 억제제와 함께 성장인자 억제제를 사용한 폐암의 치료
|